
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
View the Pharmaceutical Executive June 2025 issue in an interactive format.
over 1 year ago
Role Eye-Openerover 1 year ago
2025 Pharm Exec Top 50 Companiesover 1 year ago
Beyond the Pharma 50: Key Data Trends and Highlightsover 1 year ago
Jim Weiss: Molded in Mentorshipover 1 year ago
Reinventing Pharma Sales Force Effectivenessover 1 year ago
Earned Media and PBMs: Proactive Pathways for Image Boostover 1 year ago
Rethinking Audience Modeling: AI, Regulations, & More





